At Igenomix, a company specialized on reproductive genetics and prenatal diagnosis, we work to make a world in which infertility is no longer an impossible barrier. Today, despite the Covid 19 pandemic, we remain more committed than ever to this goal.
We all face a challenging environment, and Igenomix has taken all the necessary measures to minimize the potential impact on the health of our employees, customers and patients. Extra precautions have been taken, including home working, reduced travel/visits, a focus on good hygiene, and reorganization of our lab teams to mitigate the possible effects of the coronavirus.
Today, our 450 employees located in 23 labs across the globe, including Los Angeles (US), Valencia (Spain), Marostica (Italy), and Hangzhou (China) remain operational. Every one of our labs continues to work on delivering our mission, despite current conditions.
Current air passenger travel restrictions do not apply to international parcel operators, who continue to collect and transport samples. We want to assure you that the Igenomix teams are doing everything possible to continue to provide our services with minimal disruption.
If you have any specific concerns or questions, please contact your local Igenomix team.
Igenomix will continue informing about any relevant update.